Dr. Mark Pegram and Dr. Neil Iyengar – T-DXd’s Rise in HER2+ & HER2-Low Breast Cancer

Playlist - Dr. Mark Pegram & Dr. Neil Iyengar

Analyzing the role of T-Dxd in DB06 HER2-low and HER2-ultralow advanced breast cancer

1 min read

T-Dxd Role in HER2-Low: Establishing the First Cytotoxic Line After Endocrine Therapy Failure

1 min read